Thema: US58933Y1055
Merck & Co., US58933Y1055
Flatlay mit Aktienzertifikat und ISIN-Karte US58933Y1055 zeigt Investment in Merck & Co. Inc. symbolisch - Foto: THN
Merck & Co. stock: Q3 sales beat raises 2026 outlook
Merck & Co. stock enters Friday trading after stronger third-quarter sales. The company raised its adjusted 2026 earnings outlook.
ad-hoc-news.de, 30.10.26 16:47 Uhr
Merck & Co., US58933Y1055
Merck & Co. stock: Q3 sales beat as 2026 outlook rises
Merck & Co. stock enters Friday trading after stronger third-quarter sales and a higher 2026 adjusted earnings outlook. KEYTRUDA led oncology growth.
ad-hoc-news.de, 30.10.26 11:59 Uhr
Merck & Co., US58933Y1055
Merck & Co. stock jumps as Q3 sales beat and outlook rises ...
Merck & Co. stock gains after third-quarter sales reached USD 18.1 billion. The company raised its full-year adjusted profit outlook.
ad-hoc-news.de, 29.10.26 17:51 Uhr
Merck & Co., US58933Y1055
Merck presents sac-TMT results. Merck & Co. stock gains ...
TroFuse-005 cut death risk 32.00 percent on October 26, 2026. Merck & Co. stock costs EUR 128.60, 1.93 percent above the Xetra close.
ad-hoc-news.de, 29.10.26 11:31 Uhr
Merck & Co., US58933Y1055
HSBC raises target for Merck & Co. stock to USD 175.00
Merck reports third-quarter results October 29, 2026. Merck & Co. stock costs EUR 127.87 on October 27, 2026, up 0.20 percent versus Xetra's close.
ad-hoc-news.de, 27.10.26 17:13 Uhr
Merck & Co., US58933Y1055
Barclays raises target for Merck & Co. stock from USD 150.00 ...
Q2 revenue hit USD 16.61 billion, up 5.10 percent year over year. Merck & Co. stock costs EUR 126.26 on October 27, 2026, below the EUR 126.36 Xetra close.
ad-hoc-news.de, 27.10.26 12:07 Uhr
Merck & Co., US58933Y1055
MarketScreener puts a USD 159.76 target on Merck & Co. stock ...
Q2 revenue reached USD 16.61 billion, up 1.97 percent. Merck & Co. stock costs EUR 126.29 on October 26, 2026, down 2.27 percent versus Xetra close.
ad-hoc-news.de, 26.10.26 17:40 Uhr
Merck & Co., US58933Y1055
HSBC raises Merck & Co. stock target to USD 175.00
Second-quarter revenue was USD 16.61 billion. Merck & Co. stock costs EUR 129.39 October 26, 2026, 0.13 percent above Xetra close EUR 129.22.
ad-hoc-news.de, 26.10.26 11:40 Uhr
Merck & Co., US58933Y1055
Merck & Co. stock has ESMO event today little changed pre-market ...
Merck develops medicines and vaccines as a research-intensive biopharmaceutical company. At Lang & Schwarz the stock trades pre-market at EUR 129.47 on October 26 2026 0.19 ...
ad-hoc-news.de, 26.10.26 07:51 Uhr
Merck & Co., US58933Y1055
Merck & Co. stock trades 0.46 percent above its Xetra close ...
